FDA slams EpiPen maker
To the commenters suggesting that the FDA should do more to punish this company, consider another alternative: if the FDA actually did <i>less</i> to begin with (while still investigating and providing information transparency), we'd probably be better off.<p>Instead of relying on the government to fix the situation with slow legislation (which usually ends up with enough loopholes to be circumvented anyway), we should allow the industry to function as an actual free(ish) market. If that were the case, we would already have dozens of <i>better</i> EpiPen alternatives as a result of the previous shenanigans from these companies. In other industries, when a company's product is clearly defective, inferior or overpriced, they lose market share and are forced to either improve the product or go out of business. But when the government plays the role of (slow, expensive, often corrupt) "gatekeeper", <i>that</i> is what creates these abusive monopolies.